Affiliation:
1. From Stanford Stroke Center, Stanford University Medical Center, Palo Alto, Calif.
Abstract
Background
—Effective therapy was not available for treatment of acute stroke until 1995, when tissue plasminogen activator (tPA) was shown to improve neurological and functional outcome in stroke patients who were treated within 3 hours of symptom onset.
Summary of Review
—Currently, many patients do not qualify for tPA therapy because they present for evaluation beyond 3 hours after stroke onset. Attempts to expand the treatment window to 6 hours, using CT to select patients, have failed. Use of early MR imaging may provide significant advantages over CT for identification of patients who are likely to benefit from thrombolytic therapy because (1) the early perfusion-weighted imaging (PWI) lesion estimates the region of acute dysfunctional brain tissue, whereas the acute diffusion-weighted imaging (DWI) lesion appears to correspond to the core of the early infarction; (2) the mismatch between the acute PWI lesion and the smaller DWI lesion represents potentially salvageable brain tissue (an estimate of the ischemic penumbra); and (3) in patients with a PWI/DWI mismatch, early reperfusion is often associated with substantial clinical improvement and reversal or reduction of DWI lesion growth.
Conclusions
—Clinical trials that use new MRI techniques to screen patients may be able to identify a subset of acute stroke patients who are ideal candidates for thrombolytic therapy even beyond 3 hours after stroke onset.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)
Reference62 articles.
1. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI
2. Kidwell CS Saver JL Mattiello J Starkman S Vinuela F Duckwiler G Gobin P Vespa P Kalafut M Jahan R Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury demonstrated by diffusion/perfusion magnetic resonance imaging. Neurology . 1999;52(suppl 2):A536. Abstract.
3. Tissue Plasminogen Activator for Acute Ischemic Stroke
4. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
5. Practice Advisory [RETIRED]
Cited by
203 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献